Silvia Gentili

1.2k citations
32 papers · 450 indexed · h-index 12
Topics
Multiple Myeloma Research and Treatments (25 papers)Protein Degradation and Inhibitors (18 papers)Peptidase Inhibition and Analysis (12 papers)
Partner nations
ItalyNetherlandsGermany

In The Last Decade

Silvia Gentili

32 papers receiving 437 citations

Peers

Silvia Gentili
Comparison fields: 5 of 77
  • Hematology 266
  • Molecular Biology 258
  • Oncology 176
  • Pharmacology 60
  • Radiology, Nuclear Medicine and Imaging 36
Replace Hiromi Tanii with:
Hiromi Tanii Japan
Guowei Dai China
Solenn Le-Guennec France
A M Faussat France
Greta Cipriani Italy
Wanmao Ni China
Julie Errington United Kingdom
Xiangjie Lin China
Adrian Stecuła United States
Hans-Peter Gschwind Switzerland
Silvia Gentili relative to Hiromi Tanii Japan Hiromi Tanii's profile →
Citations per field
00.5×4.8×
Hiromi Tanii · 1×
Citations per year

Countries citing papers authored by Silvia Gentili

Since Specialization
Citations

This map shows the geographic impact of Silvia Gentili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Gentili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Gentili more than expected).

Fields of papers citing papers by Silvia Gentili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Gentili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Gentili. The network helps show where Silvia Gentili may publish in the future.

Co-authorship network of co-authors of Silvia Gentili

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Gentili. A scholar is included among the top collaborators of Silvia Gentili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Gentili. Silvia Gentili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 32
2 1
3 5
4 41
5 4
6 7
7 45
8 6
9 19
10 41
11 36
12 17
13 14
14 9
15 1
16 12
17 2
18 4
19 23
20
Carcinoma of the duodenum: management and survival in 14 cases.
6

About Silvia Gentili

Silvia Gentili is a scholar working on Hematology, Oncology and Molecular Biology, having authored 32 papers that have together received 450 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (18 papers) and Peptidase Inhibition and Analysis (12 papers). The work is most often cited by research in Hematology (266 citations), Oncology (176 citations) and Molecular Biology (258 citations). Silvia Gentili has collaborated with scholars based in Italy, Netherlands and Germany. Frequent co-authors include Massimo Offidani, Laura Corvatta, Pietro Leoni, Claudia Polloni, Francesco Alesiani, Massimo Catarini, Sagar Lonial, Giorgio Santoni, Claudio Cardinali and Maria Beatrice Morelli. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026